The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized double-blind placebo-controlled phase 2 study of bemarituzumab combined with modified FOLFOX6 (mFOLFOX6) in first-line (1L) treatment of advanced gastric/gastroesophageal junction adenocarcinoma (FIGHT).
 
Zev A. Wainberg
No Relationships to Disclose
 
Peter C. Enzinger
No Relationships to Disclose
 
Yoon-Koo Kang
No Relationships to Disclose
 
Kensei Yamaguchi
No Relationships to Disclose
 
Shukui Qin
No Relationships to Disclose
 
Keun-Wook Lee
No Relationships to Disclose
 
Sang Cheul Oh
No Relationships to Disclose
 
Jin Li
No Relationships to Disclose
 
Haci Mehmet Turk
No Relationships to Disclose
 
Alexandra Carolina Teixeira
No Relationships to Disclose
 
Giovanni Gerardo Cardellino
No Relationships to Disclose
 
Raquel Guardeño
No Relationships to Disclose
 
Siddhartha Mitra
No Relationships to Disclose
 
Yingsi Yang
No Relationships to Disclose
 
Helen Collins
No Relationships to Disclose
 
Daniel V.T. Catenacci
No Relationships to Disclose